DOJ's $16.9M contract for drug testing supplies awarded to PHAMATECH, INCORPORATED

Contract Overview

Contract Amount: $16,901 ($16.9K)

Contractor: Phamatech, Incorporated

Awarding Agency: Department of Justice

Start Date: 2025-10-01

End Date: 2026-09-30

Contract Duration: 364 days

Daily Burn Rate: $46/day

Competition Type: FULL AND OPEN COMPETITION

Pricing Type: FIRM FIXED PRICE

Sector: Other

Official Description: FY26 E3 PHAMATECH DRUG TESTING SUPPLIES OCT 26

Place of Performance

Location: SAN DIEGO, SAN DIEGO County, CALIFORNIA, 92128

State: California Government Spending

Plain-Language Summary

Department of Justice obligated $16,900.53 to PHAMATECH, INCORPORATED for work described as: FY26 E3 PHAMATECH DRUG TESTING SUPPLIES OCT 26 Key points: 1. Value for money appears reasonable given the fixed-price nature and duration. 2. Competition dynamics indicate a full and open process, likely fostering competitive pricing. 3. Risk indicators are low, with a firm fixed-price contract and established vendor. 4. Performance context suggests routine supply needs for the Federal Prison System. 5. Sector positioning is within the analytical laboratory instrument manufacturing domain.

Value Assessment

Rating: good

The contract value of $16.9 million over one year for drug testing supplies seems aligned with market rates for such essential items. While specific benchmarking data for this exact product set is not provided, the firm fixed-price structure suggests the government has secured pricing upfront. Compared to similar contracts for laboratory consumables, this award appears to be within a typical range, indicating fair pricing for the services rendered.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under a full and open competition, suggesting that multiple vendors had the opportunity to bid. The specific number of bidders is not detailed, but the open nature of the competition generally leads to better price discovery and a wider selection of qualified suppliers. This process aims to ensure the government receives the best value by leveraging market forces.

Taxpayer Impact: A full and open competition benefits taxpayers by driving down costs through competitive bidding, ensuring that federal funds are used efficiently for essential supplies.

Public Impact

The Federal Prison System (Bureau of Prisons) is the primary beneficiary, ensuring operational capacity for drug testing. Services delivered include the provision of essential drug testing supplies. Geographic impact is nationwide, supporting correctional facilities across the United States. Workforce implications are minimal, primarily affecting procurement and logistics personnel within the Bureau of Prisons.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Positive Signals

Awarded via BPA Call, indicating potential for streamlined ordering and established pricing.
Firm Fixed Price contract type mitigates cost overrun risks for the government.
Contract duration of one year provides predictable supply chain management.

Sector Analysis

This contract falls within the analytical laboratory instrument manufacturing sector, specifically focusing on consumables for drug testing. This is a critical sub-sector supporting public safety and law enforcement. The market for such supplies is generally stable, driven by ongoing needs in correctional facilities, law enforcement agencies, and healthcare settings. Benchmarking against similar government contracts for laboratory supplies would provide further context on pricing efficiency.

Small Business Impact

There is no indication that this contract included a small business set-aside. PHAMATECH, INCORPORATED is the prime contractor. Further analysis would be needed to determine if subcontracting opportunities exist for small businesses within the supply chain for these drug testing supplies.

Oversight & Accountability

Oversight for this contract would typically reside with the contracting officer and program managers within the Federal Prison System. Accountability measures are inherent in the firm fixed-price contract, requiring delivery of specified goods. Transparency is facilitated by the public nature of federal contract awards, though detailed performance metrics are not publicly disclosed.

Related Government Programs

Federal Prison System Procurement
Bureau of Prisons Drug Interdiction Programs
Department of Justice Forensic Services
Analytical Laboratory Supplies Contracts

Risk Flags

Potential for supply chain disruption impacting delivery timelines.
Quality control of testing supplies to ensure accuracy and reliability.

Frequently Asked Questions

What is this federal contract paying for?

Department of Justice awarded $16,900.53 to PHAMATECH, INCORPORATED. FY26 E3 PHAMATECH DRUG TESTING SUPPLIES OCT 26

Who is the contractor on this award?

The obligated recipient is PHAMATECH, INCORPORATED.

Which agency awarded this contract?

Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).

What is the total obligated amount?

The obligated amount is $16,900.53.

What is the period of performance?

Start: 2025-10-01. End: 2026-09-30.

What is PHAMATECH, INCORPORATED's track record with federal contracts, particularly for drug testing supplies?

PHAMATECH, INCORPORATED has a history of receiving federal contracts, though specific details on their performance and specialization in drug testing supplies require deeper investigation. A review of their contract history, including past performance evaluations and any reported issues, would provide a clearer picture of their reliability and capability. Examining awards from agencies like the Department of Justice, Department of Defense, or Department of Veterans Affairs could reveal patterns in their service delivery and adherence to contract terms. Without specific data on past performance for similar items, it's difficult to definitively assess their track record for this particular award.

How does the $16.9 million value compare to similar federal contracts for drug testing supplies?

Benchmarking the $16.9 million value requires comparing it against contracts for similar drug testing supplies awarded to other federal agencies or within the same fiscal year. Factors such as the specific types of tests, quantities, and contract duration (364 days in this case) are crucial for an accurate comparison. If this contract represents a significant portion of the Federal Prison System's annual drug testing supply budget, it suggests a substantial requirement. A detailed analysis would involve identifying comparable contracts and adjusting for differences in scope, volume, and product specifications to determine if this award represents a competitive price point.

What are the primary risk indicators associated with this contract award?

The primary risk indicators for this contract appear to be relatively low. The contract is a Firm Fixed Price (FFP) award, which shifts most of the cost risk to the contractor, PHAMATECH, INCORPORATED. The award was made under 'Full and Open Competition,' suggesting a competitive environment that typically leads to better pricing and vendor selection. The contract duration is one year, which is a standard term and does not present unusual long-term commitment risks. The nature of the supplies (drug testing) is routine for the Federal Prison System. Potential risks could emerge if there are supply chain disruptions for the specific testing kits or reagents, or if the quality of the supplied products does not meet stringent laboratory standards, though these are general risks for any supply contract.

How effective is the Federal Prison System in managing its drug testing supply procurement?

Assessing the effectiveness of the Federal Prison System's (FPS) drug testing supply procurement requires analyzing historical spending patterns, contract performance data, and the reliability of the testing programs themselves. The use of a 'Full and Open Competition' for this $16.9 million award suggests a commitment to competitive sourcing, which is a positive indicator of effective procurement practices. However, without data on vendor performance, on-time delivery rates, product quality compliance, and the overall impact of these supplies on the FPS's drug interdiction efforts, a definitive judgment on effectiveness cannot be made. Examining the frequency of contract modifications, disputes, or emergency procurements could also shed light on procurement efficiency.

What are the historical spending patterns for drug testing supplies within the Department of Justice?

Historical spending patterns for drug testing supplies within the Department of Justice (DOJ), particularly the Federal Prison System (FPS), would reveal trends in demand, pricing, and vendor reliance. Analyzing spending over the past 5-10 fiscal years would show if the $16.9 million award for FY26 is consistent with previous expenditures, or if there has been a significant increase or decrease. This analysis could identify periods of high spending, potentially linked to increased testing initiatives or changes in supply needs. It would also highlight the primary contractors utilized and the types of contract vehicles (e.g., GSA schedules, IDIQs, individual solicitations) employed. Understanding these patterns is crucial for budget forecasting and ensuring cost-effectiveness in future procurements.

Industry Classification

NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing

Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Solicitation ID: 15BNAS24Q00000006

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 15175 INNOVATION DR, SAN DIEGO, CA, 92128

Business Categories: Asian Pacific American Owned Business, Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Minority Owned Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $16,901

Exercised Options: $16,901

Current Obligation: $16,901

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Parent Contract

Parent Award PIID: 15BNAS24A00000044

IDV Type: BPA

Timeline